Steris Plc
Research Steris Plc (STE) on Bullrun: valuation model: 1.5% overvalued, market cap USD 23.05B, P/E 28.9, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTE
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal1.5% overvalued
- Market capUSD 23.05B
- P/E28.9
- Dividend yield0.8%
- Financial periodFY2026
- RevenueUSD 5.94B
- Revenue growth8.7%
- Net incomeUSD 782.30M
- Free cash flowUSD 972.40M
- Gross margin44.2%
Valuation Snapshot
Bullrun's latest valuation model marks Steris Plc as 1.5% overvalued; latest market cap is USD 23.05B; P/E is 28.9; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 28.9x versus a Healthcare sector median of 24.46x (18.2% above).
Latest dividend yield is 0.81% versus a Healthcare sector median of 2.11% (61.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 5.94B | USD 782.30M | USD 972.40M | 44.2% | 7.93 | USD 439.60M | USD 1.93B | USD 7.18B |
| FY2025 | USD 5.46B | USD 614.60M | USD 778.00M | 44.0% | 6.2 | USD 171.70M | USD 2.04B | USD 6.60B |
| FY2024 | USD 5.14B | USD 378.20M | USD 613.00M | 43.2% | 3.81 | USD 207.02M | USD 3.21B | USD 6.30B |
| FY2023 | USD 4.54B | USD 107.03M | USD 394.98M | 43.7% | 1.07 | USD 208.36M | USD 3.08B | USD 6.08B |
| FY2022 | USD 4.22B | USD 243.89M | USD 397.25M | 44.6% | 2.48 | USD 348.32M | USD 3.09B | USD 6.53B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 23.05B | 28.9 | 0.8% | 1.89 |
| 2025 | 2025-12-31 | USD 24.88B | 35.1 | 0.2% | 0.63 |
| 2024 | 2024-12-31 | USD 20.20B | 43.6 | 1.1% | 2.18 |
| 2023 | 2023-12-29 | USD 21.72B | 39.8 | 0.9% | 1.98 |
| 2022 | 2022-12-30 | USD 18.44B | n/a | 1.0% | 1.8 |
| 2021 | 2021-12-31 | USD 24.37B | 83.6 | 0.7% | 1.66 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.89 USD, yield 0.8%.
| Year | Dividends/share |
|---|---|
| FY2026 | 2.46 USD |
| FY2025 | 2.23 USD |
| FY2024 | 2.03 USD |
| FY2023 | 1.84 USD |
| FY2022 | 1.69 USD |
About Steris Plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Steris Plc overvalued or undervalued?
Bullrun's valuation model currently marks Steris Plc as 1.5% overvalued.
What is Steris Plc's market cap?
Steris Plc's market capitalization is USD 23.05B.
What is Steris Plc's P/E ratio?
Steris Plc's price-to-earnings (P/E) ratio is 28.9.
Does Steris Plc pay a dividend?
Steris Plc has a dividend yield of 0.8%.
What does Steris Plc do?
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.